Clinical trialNCT06529419CompletedPhase 2Interventional

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

SponsorAstraZenecaEnrollment537Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Njira Lugogo
Univeristy of Michigan Hospital, Ann Arbor, MI, US
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

196 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Alberdi, Argentina
Research Site
CABA, Argentina
Research Site
Capital Federal, Argentina
Research Site
Mar del Plata, Argentina
Research Site
Quilmes, Argentina
Research Site
Rosario, Argentina
Research Site
San Fernando, Argentina
Research Site
San Juan Bautista, Argentina
Research Site
San Miguel de Tucumán, Argentina

Belgium

Research Site
Duffel, Belgium
Research Site
Mechelen, Belgium
Research Site
Namur, Belgium

Chile

Research Site
Chile, Chile
Research Site
Curicó, Chile
Research Site
Santiago, Chile
Research Site
Santiago, Chile
Research Site
Talca, Chile
Research Site
Viña del Mar, Chile

China

Research Site
Baotou, China
Research Site
Changchun, China
Research Site
Chengdu, China
Research Site
Chongqing, China
Research Site
Guangzhou, China
Research Site
Guiyang, China
Research Site
Hefei, China
Research Site
Hohhot, China
Research Site
Jinan, China
Research Site
Lanzhou, China
Research Site
Nanchang, China
Research Site
Ningbo, China
Research Site
Qingdao, China
Research Site
Shanghai, China
Research Site
Shenyang, China
Research Site
Shijiazhuang, China
Research Site
Taiyuan, China
Research Site
Wenzhou, China
Research Site
Xuzhou, China

Czechia

Research Site
Brno, Czechia
Research Site
Hradec Králové, Czechia
Research Site
Jindřichův Hradec, Czechia

156 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Aug 2024
Primary completion: 4 Feb 2026
Completion: 4 Feb 2026
Last update posted: 2 Mar 2026
Registered enrollment: 537
Registry id: NCT06529419

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.